These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 946524)

  • 41. [Effectiveness of selective anti-measles reimmunization of risk-group children].
    Sokhin AA; Ignatov SA
    Pediatriia; 1988; (9):69-72. PubMed ID: 3200643
    [No Abstract]   [Full Text] [Related]  

  • 42. [Serological examination in measles].
    Janout V
    Cesk Epidemiol Mikrobiol Imunol; 1979 Apr; 28(3):144-50. PubMed ID: 158438
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunity against measles among vaccinated school going children in Zahedan, southeast of Iran.
    Mood BS; Naini RN; Salehi M; Kouhpayeh HR; Azad TM; Poor TN
    Indian J Med Microbiol; 2005 Oct; 23(4):274-5. PubMed ID: 16327132
    [No Abstract]   [Full Text] [Related]  

  • 44. Measles immunization. Successes and failures.
    Yeager AS; Davis JH; Ross LA; Harvey B
    JAMA; 1977 Jan; 237(4):347-51. PubMed ID: 576165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Failure of attenuated viral vaccine in prevention of atypical measles.
    Chatterji M; Mankad V
    JAMA; 1977 Dec; 238(24):2635. PubMed ID: 579203
    [No Abstract]   [Full Text] [Related]  

  • 46. Seroconversion following measles immunisation.
    Swami SS; Chandra S; Dudani IU
    J Commun Dis; 1987 Jun; 19(2):141-5. PubMed ID: 3454353
    [No Abstract]   [Full Text] [Related]  

  • 47. [Intranasal revaccination of children with live measles vaccine: development of local immunity].
    Liashenko VA; Iuminova NV; Krasnova VP; Glazkova NV; Svirina VS
    Vopr Virusol; 1999; 44(3):124-6. PubMed ID: 10392436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sustained Responses to Measles Revaccination at 24 Months in HIV-infected Children on Antiretroviral Therapy in Kenya.
    Newman LP; Njoroge A; Magaret A; Chohan BH; Gitomea VW; Wald A; Gorstein J; Overbaugh J; Wamalwa D; Maleche-Obimbo E; Nduati R; Farquhar C
    Pediatr Infect Dis J; 2017 Dec; 36(12):1148-1155. PubMed ID: 28198789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Fourth report to the medical research council by the measles sub-committee of the committee on development of vaccines and immunisation procedures.
    Lancet; 1977 Sep; 2(8038):571-5. PubMed ID: 71396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Revaccination against measles--a pilot study.
    Watson GI; Nichols JA; Robshaw JR
    J R Coll Gen Pract; 1975 Dec; 25(161):863-73. PubMed ID: 1223275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effectiveness of revaccination against measles].
    Bolotovskiĭ VM; Gelikman BG; Kibrik LI; Auzinia AV; Glinskaia EV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Feb; (2):46-50. PubMed ID: 419909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistence of immunity against measles in persons immunized with Edmonston-Zagreb vaccine.
    abu Eldan J; Borćić B; Smerdel S
    Acta Med Croatica; 1991; 45(4-5):297-304. PubMed ID: 1726513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
    Fulginiti VA; Helfer RE
    JAMA; 1980 Aug 22-29; 244(8):804-6. PubMed ID: 7392190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Anti-measles humoral immunity in children with thymus hyperplasia].
    Gurvich EB; Lysenkova NV; Shishatskaia SN; Vaganov PD; Ozeretskovskiĭ NA
    Pediatriia; 1989; (9):31-3. PubMed ID: 2587164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Vaccination against measles].
    Domorázková E
    Cesk Pediatr; 1977 Dec; 32(12):732-4. PubMed ID: 610938
    [No Abstract]   [Full Text] [Related]  

  • 57. [The results of multiyear observations on the duration of the maintenance of immunity in those vaccinated and revaccinated against and recovered from measles].
    Sliusar' LI; Sokhin AA; Radomskaia FS; Degtiareva GV; Panasenko LI; Litvinova TP; Komarevskaia RV; Bol'shinskaia ZhI
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Aug; (8):66-70. PubMed ID: 2239007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Postvaccinal immunity study of children inoculated with a live measles vaccine].
    Bol'shakova SL
    Tr Inst Im Pastera; 1979; 53():75-8. PubMed ID: 162466
    [No Abstract]   [Full Text] [Related]  

  • 59. Measles vaccination. VIII. The occurrence of antibodies against virus envelope components after immunization with inactivated vaccine. Effects of revaccination with live measles vaccine.
    Norrby E; Lagercrantz R
    Acta Paediatr Scand; 1976 Mar; 65(2):171-6. PubMed ID: 1258633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.